ALVO (Alvotech SA) Prakiraan volume dodolan
Under the leadership of Robert Weissman, Alvotech is effectively challenging the monopoly of high-cost medications. The company's projected sales volume demonstrates stability, and this metric has reached the level of 0.49. Business resilience is bolstered by global alliances for the distribution of biosimilars. Furthermore, the European production base minimizes the risks of supply chain disruptions, providing a reliable foundation for growth.
Ringkesan rincian data analitis Alvotech S.A. (ALVO)
- nilai saham lan prakiraan konsensus rega:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas Alvotech|ALVO - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Alvotech Corp|ALVO - Tanggungan utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Alvotech S.A.|ALVO - Utang jangka dawa|Utang jangka cendhak perusahaan Alvotech|Rasio cepet alvotech.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
ALVO - Bathi pungkasan|Proyeksi bathi mangsa ngarep Alvotech|ALVO - Pangali P/E|Rega marang bathi mangsa ngarep Alvotech SA|ALVO - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Alvotech S.A.|ALVO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Alvotech|ALVO - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan alvotech.com|ALVO - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Alvotech
- rincian pendapatan lan dodolan emiten:
Ringkesan analisis perusahaan:Alvotech
This indicator assesses revenue potential by comparing actual transactions with historical data to identify long-term market cycles and minimize volatility risks. By analyzing the sales pipeline dynamics of Alvotech (ALVO), investors can observe the scaling effect of the biosimilar ecosystem, where replacing expensive reference products with affordable copies through global partnerships directly converts into growth in projected sales volumes.
Pesaing Alvotech (ALVO)
Prakiraan pendapatan perusahaan Haleon plc (HLN)|KVUE (kenvue.com) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan VRNA (Verona Pharma)|Prakiraan volume dodolan Jyong Biotech Limited MENS|LGND - Prakiraan pendapatan perusahaan|AMRX: Prakiraan pendapatan perusahaan|PRGO (Perrigo Company plc) - Volume dodolan mangsa ngarep perusahaan|LQDA (liquidia.com) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan Galapagos|Volume dodolan sing dikarepake perusahaan ANI Pharmaceuticals Inc ANIP|Volume dodolan mangsa ngarep perusahaan MNKD (MannKind Corp.)|Prakiraan volume pendapatan perusahaan AMPH|Prakiraan volume dodolan PCRX (Pacira BioSciences)|ars-pharma.com (SPRY) - Volume dodolan sing dikarepake perusahaan|Theravance Biopharma, Inc. - Prakiraan volume dodolan|Aquestive Therapeutics Inc (AQST) - Volume dodolan mangsa ngarep perusahaan|SCPH: Prakiraan volume dodolan|Tectonic Therapeutic - Pendapatan mangsa ngarep perusahaan|TNXP (Tonix Pharmaceuticals) - Prakiraan volume dodolan|Prakiraan volume dodolan SXT China|Prakiraan pendapatan perusahaan Eupraxia Pharmaceuticals (EPRX)|Prakiraan pendapatan perusahaan BHST (BioHarvest Sciences, Inc.)|Invizyne Technologies, Inc. - Volume dodolan mangsa ngarep perusahaan|Oramed - Prakiraan pendapatan perusahaan|ENTX - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan ipatherapeutics.com|ABVC BioPharma, Inc. (ABVC) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan CPIX (Cumberland Pharmaceuticals Inc)|QNTM (Quantum BioPharma Limited) - Prakiraan volume dodolan|FGEN: Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan TELO|Prakiraan volume dodolan ranitherapeutics.com (RANI)|Prakiraan pendapatan perusahaan Synergy CHC SNYR|Pendapatan mangsa ngarep perusahaan RLYB|LEXX - Prakiraan pendapatan perusahaan|Pulmatrix Corporation (PULM) - Volume dodolan mangsa ngarep perusahaan|PTHL: Prakiraan volume dodolan|Aptorum Group (APM) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan LYRA|IBO: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan TNF Pharmaceuticals (TNFA)|YCBD - Volume dodolan sing dikarepake perusahaan|PainReform Ltd. - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume pendapatan perusahaan CYTO (Altamira Therapeutics Ltd)|Lipella Pharmaceuticals, Inc. - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan OPTN (OptiNose Inc)|PIRS: Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Procaps Group Corp (PROC)|Prakiraan pendapatan perusahaan Petros Pharmaceuticals|QLI: Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan SLRN|Prakiraan volume dodolan TFF Pharmaceuticals Inc. (TFFP)
